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Several  years  ago,  an  hypothesis  was  proposed  that  the  first  of  the  four 
recognized components of complement was the precursor of an enzyme (1). 
This view was based in part upon observations of the effect of proteolytic enzymes 
upon  human  complement.  Streptokinase  is  an  activator  of plasmin,  a  proteolytic 
enzyme of plasma most effective at neutrality.  The complement activity of human 
serum was inhibited by the addition of streptokinase (2). Analysis demonstrated that 
this loss of complement activity was primarily the result of inactivation of the first, 
second,  and  fourth  components of  complement.  However,  the  inactivation  of the 
second and fourth components occurred only in serums containing the first component 
(1). These experiments suggested that the streptokinase had activated plasmin which 
in turn had converted the first component of complement into an  agent which in- 
hibited the activity of the second and fourth components. 
The possibility that  the first component of human complement might be a  pro- 
enzyme has found support in two separate lines of study. In the first group of experi- 
ments, it was observed that under certain conditions a partially purified preparation 
of the first component rapidly lost its hemolytic activity. In its stead, the preparation 
acquired the capacity to inactivate complement and to hydrolyze certain synthetic 
amino acid esters  (3~ 4).  In the second group of experiments,  aggregates of antigen 
and  antibody were  mixed  with  fresh  human  serum.  This  procedure  resulted  in  a 
demonstrable  loss from the  serum  of activity attributable  to  the first  component. 
It was then possible to elute from the aggregates of antigen and antibody one or more 
factors which inactivated  complement and hydrolyzed the  same amino acid esters 
as the preparations derived from the partially purified first component (3, 5).  These 
observations suggested that the first component of complement may have been the 
precursor of an enzyme tentatively identified as an esterase  (3-5). The inhibition of 
the hemolytic action of guinea pig complement by diisopropyl fluorophosphate,  an 
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agent known to  inhibit other  esterases,  is consonant with  this view  (6,  7).  Becker 
(7,  8),  using an entirely different approach,  has  reached  the  same conclusion con- 
cerning the nature of the first component of guinea pig serum. 
The  present report  describes some of the  properties  of an esterase  derived 
from preparations of the first component of complement or eluted from aggre- 
gates of antigen and antibody which had been treated  with fresh serum. The 
effect  of  the  esterase  was  tested  against  a  variety of possible substrates.  N- 
acetyl-L-tyrosine  ethyl  ester  was  the  one  most  readily  digested.  Using  this 
substrate,  an assay was  devised with which  to  test certain aspects  of the  ki- 
netics of the esterase.  In addition, it was possible to demonstrate that human 
serum  inhibited the  esterase.  The  implications of  these  observations  will be 
discussed. 
Nomenclature  and Materials 
The method of preparation of partially purified first component of kuman complement (C'I) 
has been described  previously. Rat and rabbit first component were made by the same tech- 
nique. The partially purified human C'I contained 17 to 25 per cent of the C'1 activity  present 
in the original serum, with a purification  of 30- to 50-fold, representing  about 0.6 per cent of the 
original serum protein. It was heterogeneous in the ultracentrifuge, with at least three measur- 
able components at pH 5.5 and ionic strength 0.30. There were no measurable amounts of the 
second and fourth components of complement, and only traces of the third component. In 
preparations concentrated 20-fold over the starting material, the concentration of properdin 
(9) was about 8 units per ml. when the first component was prepared from serum, and 1 unit 
or less per ml., when it wasprepared from serum from which the bulk of the properdin had been 
removed. Partially purified C'1 also contained appreciable amounts of plasminogen; the plas- 
rain which formed upon the addition of streptokinase digested fibrin, casein, para-toluenesul- 
fonyl-L-arginine  methyl ester, and L-lysine ethyl ester, known substrates of plasmin (10). The 
recently described clot-promoting fractions, Christmas factor (plasma thromboplastin compo- 
nent), and Hageman factor were present in large amounts. In some preparations, traces of 
thrombin, and  perhaps  prothrombin  or  proconvertin were  present.  Neither  proaccelerin, 
cholinesterase,  nor acid or alkaline phosphatase could be detected. The preparation of partially 
purified C'I was stored at -25°C. at pH 5.5 and ionic strength 0.30. 
Partially purified  C'I  rapidly lost  its  hemolytic properties and  acquired complement- 
inactivating and esterase  activities when adjusted to physiologic pH and ionic strength in the 
absence of inhibitors. This new product has been designated activated C'1, although it is rec- 
ognized that the complement-inactivating  and esterase properties are not necessarily derived 
from the first component of complement itself (5).  In earlier studies the activated C'I was 
referred  to as "converted C'I." Activated C'I was prepared by adding an equal volume of 
water to suspensions  of partially purified C'1, and adjusting the pH to 7.0-7.8 by the addition 
of 0.05 N sodium hydroxide. The clear solution of activated C'I, now at ionic strength 0.15 and 
concentrated 10-fold with respect to serum, was incubated at 37°C. for 15 minutes to insure 
complete activation of the esterase.  It was kept in ice water until used the same day, or stored 
at --25°C. for several weeks, without demonstrable loss of activity. However, when the frozen 
material was thawed, a precipitate formed so that the preparation required thorough stirring 
before use. 
The term duate AE is used to describe the eluate derived from aggregates of an antigen of 
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been incubated with normal human serum.  Its method of preparation had  been described 
elsewhere (5). Eluate AE prepared from fresh human serum and concentrated 10-fold  con- 
tained about 0.04 rag. of nitrogen per ml. of solution. It was dissolved in 0.15 N sodium chloride. 
Small amounts of Hageman factor and of streptokinase-activable plasminogen were present. 
It did not contain measurable amounts of the components of complement, properdin, acid or 
alkaline  phosphatase,  cholinesterase,  prothrombin,  proconvertin,  proaccelerin,  Christmas 
factor, or thrombin. Eluate AE had complement-inactivating and esterase activities qualita- 
tively indistinguishable from activated C'I. 
The sodium phosphate buffer used was composed of 1.82 grams of NaH~.PO,-H~O and 16.75 
grams of Na~IPO,- 12H~O per liter, and had a pH of 7.4 and ionic strength 0.15. The barbital- 
saline buffer was prepared by dissolving 2.76 grams of barbital, 2.06 grams of sodium barbital, 
and 7.40 grams of sodium chloride in one liter of water, and consisted of 0.025 M barbital and 
0.125 •  sodium chloride at pH  7.5 and ionic strength 0.15. Michaclis'  acetate-barbital-saline 
buffers were prepared according to published directions, and over the range of pH used were at 
ionic strength 0.15 (11). 
Synthoti¢  substrates, obtained from commercial sources or synthesized in laboratories of 
the Department of Chemistry, Western Reserve University, were dissolved in suitable amounts 
in a buffer solution of sodium phosphate at pH 7.4 unless otherwise indicated. The solutions 
were adjusted to pH  7.4 by the addition of 0.15 N sodium hydroxide or hydrochloric acid. 
Certain of the substrates were soluble only in the presence of suitable amounts of 2-methoxy- 
ethanol (methyl cellosolve). The synthetic substrates included esters or amides of amino acids 
or simple dipeptides or tripeptides. 
Protein substrates were prepared in a variety of ways. Casein (Hammerstan quality, Nutri- 
tional Biochemicals Co.)  was dissolved at a  concentration of 5  per cent in 0.15  N sodium 
hydroxide and then dialyzed for 48 hours against barbital-saline buffer. A 2.2 per cent solution 
of denatured hemoglobin (Armour) was prepared by published methods (12). A 5 per cent solu- 
tion of bovine albumin  (Armour) was prepared by diluting a  30 per cent stock solution with 
0.15 N soldium chloride. Crystallized egg albumen  (Armour) was dissolved at a  concentration 
of 1 per cent in sodium phosphate buffer. Crystalline beta-lactoglobulin (United States Depart- 
ment of Agriculture Eastern Utilization Research Branch) was dissolved at a  concentration 
of 1 per cent in barbital-saline buffer. Edestin and lactalbumin (obtained from The Rockefeller 
Institute for Medical Research in 1946) were suspended in a concentration of 10 mg. per 5 ml. 
of  1 N sodium chloride. Myomelrium,  obtained from an intact surgically removed human 
uterus, was washed 20 times with 0.15 N solution of sodium chloride, crushed in a mortar, and 
pulverized in a hand homogenizer. It was then washed with 10 ml. of 0.15 N sodium chloride, 
centrifuged for 15 minutes at  room temperature at  2000 R.P.M. and  then  resuspended,  re- 
homogenized, and recentrifuged two more times. The myometrial suspension was  then re- 
suspended in barbital-saline buffer in a  concentration of 5 grams per 100 ml. Human serum, 
when used as substrate, was diluted to one-tenth its original concentration with 0.15 N sodium 
chloride. Human plasma,  obtained by centrffugafion of blood rendered incoagulable by the 
addition of one-ninth part of 3.8 per cent sodium citrate, was diluted to one-tenth its original 
concentration by the addition of a mixture of I part of 3.8 per cent sodium citrate and 4 parts 
of 0.15 N sodium chloride, to inhibit clotting. Gelatin  (Dffco) was dissolved at  70-80°C. in 
phosphate buffer, in a concentration of 5 per cent and then maintained at 37°C. for immediate 
use. 
Streptokim~se ("high purity")  t, the filterable principle of cultures of beta-hemolytic strepto- 
cocci which activates plasminogen, was dissolved in a concentration of 20,000 u./ml, of barbital- 
saline buffer. 
t Streptokinase was provided through the courtesy of the Lederle Laboratories Division, 
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Crystalline soy bean inhibitor  (Nutritional Biochemicals Co.),  egg white inhibitor  (Nutri- 
tional Biochemicals Co.)  and heporin sodium  (Upjohu, 1,000  USP units per ml.) were each 
dissolved in a concentration of 10 nag. per ml. of 0.15 R sodium chloride, and pancreatir, trypsin 
inhibitor  (Nutritional Biochemicals Co.),  in  a  concentration of  1  rag.  per ml.  N-acetyl-t.- 
tyrosine when used as an inhibitor, disodium ethylene diamine tetraacetic acid  t  (sequestrene 
Na2),  sodium  ascorbate, reduced  glutathione,  hydrogen  peroxide,  and  thioglycoll@ acid  were 
neutralized with appropriate  amounts of 0.15 ~  sodium hydroxide and dissolved in 0.1  - 
concentration in 0.15 r¢ sodium chloride or phosphate buffer at ionic strength 0.15. Oxidized 
glutathione was dissolved in a concentration of 0.1 ,x in 0.2 N sodium hydroxide. A 2.5 x¢ stock 
solution of diisopropyl fluorophosphate  (Delta Chemical Works, New York,  New York) was 
prepared in lsopropyl alcohol, from which a  0.125 ~  emulsion in 0.12 ~s sodium bicarbonate 
was made just before use (6). Further dilutions of the emulsion were made in 0.15 ~  NaCI. 
Human serum, when used as an inhibitor, was diluted with one-half volume of 0.15 N sodium 
chloride. Preparations of human serum from which individual components of complement had 
been removed were prepared by published methods. The terms R1, R2, R3, and R4 will be 
used  to  designate  serum  from which the  respective components of complement had  been 
removed (13). Complement-fixed  serum was prepared by the addition of fresh human serum of 
pneumococcal specific soluble substance, type III, and purified homologous rabbit antiserum. 
The mixture was incubated at 37°C. for 1 hour, the antigen-antibody aggregate removed by 
centrifugation at 0°C., and the supernatant (complement-fixed serum) tested for complement 
components. Eight micrograms of antigen and 200 micrograms of antibody nitrogen were used 
in a  volume of 0.5 ml. for 1 ml. of human serum. The resulting treated serum contained 6 
per cent of the original C'1, no second or fourth component, and 50 per cent of the original 
third component of complement. 
Streptokinase-Treated  Serum was prepared by adding 0.5 ml. of streptokinase (2,000 units/ 
ml.) to 1 ml. of fresh human serum and incubating at 37°C. for one hour. The resulting treated 
serum contained 4 per cent of the original C'I, no second or fourth component, and 60 per cent 
of the original third component of complement. In the final mixture of enzyme and substrate, 
the concentration of all the inhibitors tested was one-fifth of the original solutions. 
Methods 
Measurement of the hydrolysis  of amino acid esters or amides or of peptides was performed by a 
minor modification of the technique of Troll, Sherry, and Wachman (10). Typically, 7 parts of 
a buffered solution of substrate were mixed with 2 parts of 0.15 x¢ sodium chloride and 1 part 
of a solution of the enzyme to be tested, and incubated in a water bath at the desired tempera- 
ture. In the case of the substrate N-acetyl-t.-tyrosine ethyl ester, the buffer, sodium chloride 
solution and enzyme were first mixed, and the substrate, dissolved in methyl ceUosolve equal 
to 5 per cent of the final mixture, was added last. The final concentration of methyl cellosolve 
in the assay mixture was 5 per cent. At the start and at appropriate intervals, samples of 1 ml. 
of the enzyme-substrate mixture were removed, mixed with 1 ml. of a 37 per cent solution of 
neutralized formaldehyde, and micro-titrated with 0.05 •  sodium hydroxide using 2 drops of 
1 per cent alcoholic phenolphthalein as the indicator. Suitable control experiments were per- 
formed, omitting enzyme or substrate from the mixture. 
The influence of pH upon the action of the enzyme was tested  by substituting Michaelis 
acetate-barbital buffer of varying pH in the ordinary assay procedure. Two drops of 5 per cent 
alcoholic solution of thymolphthalein were used as the indicator in those mixtures which were 
initially too alkaline for the use of phenolphthalein. The pH of the enzyme-substrate mixtures 
was tested at approximately 25°C.  at the beginning of the experiment, using a  Cambridge 
research model pH meter. 
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The influence of ionic stren#h was tested in an enzyme-substrate mixture composed of 1.0 
ml. of phosphate buffer, 0.25  ml. of activated C'I,  1.12  ml.  of sodium chloride solution of 
varying concentration, and 0.12 ml. of 1.6 ~  N-acetyl-z-tyrosine ethyl ester in methyl cello- 
solve. The ionic strength of the substrate itself was ignored. 
The  digestion  of  N-acetyl-~.-tyrosine  ethyl  ester,  p-toluenesulfonyl-z-arginine  methyl 
ester, benzoyl-z-arginine methyl ester, and z-lysine ethyl ester was also determined by Sherry's 
unpublished modification of the method of Hestrin (14). 
Measurement of the digestion of protein substrates other than gelatin was performed in dupli- 
cate by mixing 0.1 ml. of the enzyme preparation with 0.4 ml. of phosphate buffer and 0.5 ml. 
of substrate solution, and incubating the mixture at 37°C. for approximately 24 hours. At the 
same time, two control mixtures were incubated, namely, a mixture of 0.1 ml. of enzyme and 
0.4 ml. of buffer to which 0.5 ml. of substrate was added at the end of the period of incubation; 
and a mixture of 0.1 ml. of 0.15 z~ sodium chloride, 0.4 ml. of phosphate buffer, and 0.5 ml. of 
substrate. At the end of the period of incubation, 2.0 ml. of 0.3 N trichloracetic acid were added. 
After 30 minutes,  the precipitate which formed was  separated  by centrifugation, and  the 
tyrosine-like activity of an aliquot of 1 ml. of the supernatant solution was measured by adding 
1 ml. of 2.5 N sodium hydroxide, 6 ml. of water, 3 ml. of 20 per cent sodium carbonate solution, 
and 1 ml. of Folin-Ciocalteau reagent. The color which resulted was measured in  10 ram. 
cuvettes in a  Beckman Model B  spectrophotometer at a  wave length of 650 m/~. using as a 
standard a  solution of tyrosine which had been treated in the same fashion. Denatured hemo- 
globin was incubated in the presence of 40 per cent urea in the enzyme-substrate mixture. Since 
the preparations of l~talbumin and edestin were poorly soluble, the mixtures containing these 
substrates were agitated on a mechanical shaker during the period of incubation. 
The digestion of gdatin was  measured  by a  modification of  the  viscosimetric methods 
described by Swyer and Emmens (15). One ml. of activated Cq was added to 6.5 ml. of 5 per 
cent gelatin at 37°C.  and the mixture transferred at once to an Ostwald viscosimeter in a 
37°C. water bath. Flow times were measured at regular intervals to determine reduction of 
viscosity of gelatin by the enzyme. The flow time of water in the viscosimeters used was 
71 to 74 seconds. 
The effect of inhibitory  agents was tested by preparing a  series of tubes each containing a 
mixture of 1.62 ml. of phosphate buffer, 0.25 ml. of activated Cq, and 0.50 ml. of the solution 
to be tested or of 0.15 N sodium chloride. The tubes were then incubated at 37°C.  and at 
appropriate intervals 0.12 ml. of 1.6 ~t N-aeetyl-L-tyrosine ethyl ester in methyl cellosolve was 
added to each tube. The mixtures were then incubated for 15 additional minutes. One ml. 
aliquots were withdrawn just after the addition of substrate and after the 15 minute period, 
mixed with an equal volume of formaldehyde solution, and titrated in the manner described. 
To test for a reversal of inhibition  by thioglycolic acid, a technique suggested by the work of 
Carter and Warner (16) was used. A mixture was made of 2 parts of activated C'l and 9 parts of 
phosphate buffer. A volume of 6.88 ml. of this mixture was incubated at 37°C. for 30 minutes 
with 2.5 ml. of phosphate buffer or 0.1 ~t neutralized thioglycolic acid in phosphate buffer. The 
mixture was then dialyzed at 4°C. for 5 hours in risking no-jax cellophane casings (~ inch in 
diameter) against phosphate buffer. In duplicate, 1.375  ml. aliquots were then incubated at 
37°C. for 30 minutes with 0.5 ml. of phosphate buffer or of 0.1 M neutralized oxidized gluta- 
thione. Then 0.125 ml. of 1.6 M N-acetyl-L-tyrosine ethyl ester in methyl cellosolve was added 
and the amount digested at 37°C. in 15 minutes was determined in the usual manner. Con- 
comitantly, the immediate effect of thioglycolic acid on activated C'I was determined, omitting 
the dialysis. 
Measurement of the effect of slreptokinase and soy bean inhibitor on the digestion of casein was 
tested by a minor modification of the method used to test the digestion of other proteins. In 
duplicate, 0.9 ml. of eluate AE was incubated at 25°C.  for 10 minutes with 0.3 ml. of strepto- 
kinase solution or barbital-saline buffer. Then, to one tube of each pair was added 0.3 ml. of a 
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were added to each tube to bring the volume to 1.5 ml., and the mixtures were reincubated at 
25°C. for 30 minutes. A volume of 1.5 ml. of casein solution was then added to each tube and 
the mixtures were incubated at 37°C. for 24 hours. At that time, 1 ml. aliquots were removed 
and  tested for tyrosine-like activity in the  manner described; control mixtures, in which 
buffer was substituted for eluate AE, were tested simultaneously. 
All experiments were first performed using activated C'I as the enzyme. In most cases, the 
experiments were repeated with eiuate AE only if the preparation of activated C'I had enzy- 
matic activity against the particular substrate tested. 
Pyrex  glassware, washed with  chromic acid, was used throughout.  When enzyme and 
substrate were incubated for longer than 1 hour, a drop of toluol was added to those mixtures 
not containing methyl ceLlosolve.  All acidometric titrations were performed  with a 1 ml. micro- 
syringe (Micrometric Instrument Corporation, Cleveland). 
RESULTS 
1. Substrates of Activated C'I and Eluate AE: 
It was previously shown  that converted C'I and  eluate AE hydrolyzed p- 
toluenesulfonyl-L-arginine  methyl  ester  and  N-acetyl-L-tyrosine  ethyl  ester 
(4,  5). A  number of other synthetic amino acid esters,  amides, and peptides 
were  tested  as possible substrates  of human  activated  C'I, using  the acido- 
metric method  (Table I). The concentration of substrate in the enzyme-sub- 
strate mixture was usually 0.02 ~t, and the initial pH approximately 7.5. Only 
benzoyl-r.-arginine methyl ester, closely related to p-toluenesulfonyl-~-arginine 
methyl  ester,  N-acetyl-3,5,  dinitro-L-tyrosine  ethyl  ester  and  N-acetyl-l.- 
phenylalanine  ethyl ester,  both  closely  related  to N-acetyl-L-tyrosine ethyl 
ester, and N-acetyl-L-tryptophan ethyl ester were appreciably digested by acti- 
vated  C'I under  these conditions.  Benzoyl-L-tyrosine  ethyl  ester  was  not 
measurably hydrolyzed. Because of its relative insolubility, this ester could only 
be tested in the presence of 25 per cent methyl cellosolve. In this concentration, 
methyl cellosolve inhibited the  action of activated C'I as tested upon N-ace- 
tyl-L-tyrosine ethyl ester.  For  this  reason it  is not  certain that  under more 
suitable conditions, benzoyl-L-tyrosine ethyl ester might not be a  susceptible 
substrate. 
The relative degree of hydrolysis of 5  susceptible substrates was tested at 
37°C. at a concentration of substrate of 0.02 %  ionic strength 0.15 and pH 7.5. 
(Table  II) This  experiment was  performed at  suboptimal  concentrations  of 
both N-acetyl-L-tyrosine ethyl  ester and p-toluenesulfonyl-L-arginine methyl 
ester,  because  of the  limited solubility of the  dinitro  derivative.  N-acetyl-L- 
tyrosine ethyl ester appeared to be the most susceptible of these  substrates. 
N-acetyl-L-tryptophan  ethyl  ester  was  not  compared  in  this  experiment 
because of its poor solubility; at a concentration of 0.005 x~, it was not measur- 
ably digested  during  the  same interval of time.  All six substrates  were  also 
hydrolyzed by eluate AE. 
The assays thus far described were performed by measuring the increase in 
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TABLE  I 
Digestion of Synthetic Substrates by Activated C'I 
Substrate 
N-Acetyl-L-tyrosine ethyl ester*. :~. 
rf-Acetyl-3,5-dinitro-L-tyrosine  ethyl ester§. 
~r-Acetyl-L-tyrosine§. 
8enzoybL-tyrosine ethyl ester** 
r.-Tyrosine ethyl ester* 
DiacetybL-tyrosine** 
rf-Acetyl-L-phenylalanine ethyl ester~ 
~r-Acetyl vL alanine ethyl ester:~. 
~L-Alanine ethyl esterS. 
8enzoyl-DL-alanine ethyl ester§... 
.V-Acetylglycine ethyl esterS. 
,-Toluenesulfonyl-L-arginine methyl ester§ 
8enzoybL-arginine methyl ester* 
8enzoyl-L-arginineamide*.. 
rq-AcetybL-tryptophan ethyl ester*. 
:-Tryptophan ethyl ester* 
31ycine methyl esterl[ 
8enzoyl glycine methyl ester§. 
31ycylglycine ethyl ester* 
:-Lysine methyl ester§. 
~-Lysine ethyl ester¶... 
)L-Serine ethyl esterl[.. 
~-Cysteine ethyl ester*. 
~-Glutamic acid dimethyl ester*. 
31ycyl glycine*. 
~L-Leucyl glycine*. 
~L-Leucyl glycyl glycine*.. 
=arbobenzoxy-alpha-L-glutamyl-n-tyrosine* 
=arbobenzoxy-glycyl-L-phenylalanine*. 
8enzoyl glycine amide* .... 
:arbobenzoxy-glycyl-L-phenylalanine  amide*.. 
~-Leucinamide*. 
Concentration 
in enzyme- 
substrate 
mixture 
M 
0.02** 
0.02 
0.02 
o.oosllrl 
o.02§§ 
0.02 
o.o2~ 
0.02 
0.02 
0.02** 
0.02 
0.02 
0.02 
0.02** 
o.o1§§ 
0.02 
0.02 
0.02 
0.02 
0.02 
0.04 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.02 
0.005 
0.02 
Microequiva- 
lents of acid 
liberated in 
1 hr.  24 hr. 
18.0  -- 
1.2  11.9 
0  0 
0  0 
0  0 
0  0 
2.9  12.0 
0  0 
0  0 
0  0 
0  0 
14.2  -- 
14.7  -- 
0  0 
0.6  4.4 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
* Mann Research Laboratories, New York. 
Department of Chemistry, Western Reserve University. 
§ H. M. Chemical Co., Santa Monica, California. 
II Nutritional Biochemical Corp., Cleveland, Ohio. 
¶ Dr. S. Sherry, St. Louis. 
** 5 per cent methyl cellosolve in reaction mixture. 
:~:~ 10 per cent methyl cellosolve in reaction mixture. 
§§ 15 per cent methyl cellosolve in reaction mixture. 
II II 25 per cent methyl cellosolve in reaction mixture. 334  AN ESTERASE DERIVED  ~'ROM  COMPLEMENT 
tyrosine ethyl ester, p-toluenesulfonyl-L-arginine methyl ester and benzoyl-L- 
arginine methyl ester was also observed by the Hestrin technique (14),  which 
measures the concentration of ester linkages. 
Activated C'I of rat or rabbit origin also digested N-acetyl-L-tyrosine ethyl 
ester,  as tested by the  acidometric method, but the activity of these prepa- 
rations was much weaker than that of human origin. 
Thus far, no  protein substrates  of activated C'I  or eluate AE have been 
found. It had been shown earlier that there was no spontaneous hydrolysis of 
bovine fibrin by activated C'I or eluate AE within an hour.  However, fibrin 
was digested rapidly upon the addition of streptokinase by both these prepa- 
rations, indicating that plasminogen was present in the mixture (4, 5). In the 
absence of streptokinase, neither enzyme preparation digested  casein within 
TABLE II 
Rdative Hydrolysis of Five Susceptible Substrates by Activated C'I 
Substrate* 
N-Acetyl-L-tyrosine  ethyl ester~  ........................................ 
p-Toluenesulfonyl-T--arginine  methyl ester ................................ 
Benzoyl-L-arginine  methyl ester ....................................... 
N-Acetyl-3,5 dinitro-L-tyrosine  ethyl ester .............................. 
N-Acetyl-L-phenylalanin  e ethyl ester~  ................................... 
Microequi- 
valents of acid 
liberated in 15 
minutes 
3.6 
1.8 
0.7 
0.4 
0.0 
* All at a  concentration of 0.02 M. 
10% methyl cellosolve  in reaction mixture. 
an hour  (4,  5).  In further  experiments, both  activated  C'1  and  eluate AE 
hydrolyzed appreciable amounts of casein during a  period of 24  hours.  The 
amount digested was greatly enhanced by the addition of streptokinase in  a 
concentration of 2,000 Christensen units per ml. of enzyme-substrate mixture. 
The digestion of casein by eluate AE was inhibited by the presence of soy bean 
inhibitor in a  concentration of 0.5 mg. per ml. of enzyme-substrate mixture. 
Soy bean inhibitor did not inhibit the digestion of N-acetyl-L-tyrosine ethyl 
ester by activated C'I or eluate AE (Section 3). For this reason it seems likely 
that the digestion of casein could be attributed to the presence of plasminogen 
in these preparations. 
Digestion of gelatin, egg albumen, bovine serum albumin, human plasma 
or serum, denatured hemoglobin, edestin, lactalbumin, beta-lactoglobulin, and 
human myometrium could not be detected by the methods used. 
2. Some Studies of the Kinetics of Hydrolysis of N-Acetyl-r,-Tyrosine  Ethyl Ester 
by Activated C'1: 
(a) Substrate  Concentration.--A  constant  amount  of  N-acetyl-L-tyrosine 
ethyl ester was  hydrolyzed by activated C'I  per unit time for the first  30 OSCAR  D.  RATNOFF  AND  IRWIN  H.  LEPOW  335 
minutes of the reaction between enzyme and substrate, when the initial  con- 
centration of substrate was 0.08 M, the initial pH was 7.5, the ionic strength of 
the mixture was 0.15, and the amount of acid liberated did not exceed about 
15 microequivalents per ml. (Fig. 1). At lower conce=trations of substrate, the 
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FIG.  1.  The influence of substrate concentration on the rate of digestion of N-acetyl-L 
tyrosine ethyl ester by activated C'1. The experiment was performed at 37°C. at pH 7.5, ionic 
strength 0.15  (ignoring the substrate itself), and a  concentration of 5 per cent methyl cello- 
solve. 
degree of digestion was not a linear function of time. The values obtained were 
such that it was not feasible to calculate the Michaelis-Menten constant. 
(b) Enzyme  Co~entration.--When  the  initial  concentration of N-acetyl-T.- 
tyrosine ethyl ester in the enzyme-substrate mixture was 0.08 ~, the amount of 
acid liberated during a 20 minute period was proportional to the concentration 
of activated C'I provided that the amount of acid liberated during this period 
did not exceed about 12.5 microequivalents per ml. In other words, under these 
conditions, zero order kinetics prevailed• With higher concentrations of enzyme, 
the assay was not linear, but the exact limits of linearity were not explored since 
a  lesser amount of enzyme was used in most experiments. At the same initial 336  AN  ESTERASE  DERIVED  FROM  COMPLEMENT 
concentration of substrate, the degree of hydrolysis  was also proportional to the 
concentration of enzyme when this substrate was allowed to react with eluate 
AE. 
(c) Optimal pH.--When the initial concentrations of enzyme and substrate 
were kept constant, maximal hydrolysis of N-acetyl-r-tyrosine ethyl ester, at 
ionic strength 0.15 and substrate concentration 0.08 g, was observed between 
pH 7.5 and 8.2 (Fig. 2). 
(d) Optimal TempgraZure.--The  effect of temperature on the rate of hydrolysis 
of N-acetyl-r-tyrosine ethyl ester by activated C'1 was tested between 0 ° and 
45°C.  (Fig. 3). Between 25  ° and 38 °, the logarithm of the amount of acid liber- 
ated was proportional  to  the reciprocal  of the absolute temperature. Below 
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F1G. 2. The influence of pH on the rate of hydrolysis of N-acetyl-L-tyrosine ethyl ester by 
activated C'1 at 37°C. and ionic strength 0.15. 
25°C., the amount of substrate hydrolyzed  was relatively less, and no hydrolysis 
was measurable at 0°C. The maximal rate of hydrolysis was observed at 41°C. 
Above this temperature, the rate of digestion of substrate decreased. In other 
experiments, it was found that virtually no acid was liberated at 50°C. or 54°C. 
during a  period of 30 minutes. The decrease in enzymatic activity at these 
higher temperatures was apparently the result of denaturation of the enzyme. 
Activated C'1  was heated at 53°C.  for 30 minutes,  and then tested for its 
ability to digest N-acetyl-L-tyrosine  ethyl ester at 37°C. No measurable amount 
of enzymatic activity was demonstrable during a period of 15 minutes, although 
the unheated enzyme released 6.9 microequivalents of acid from the substrate 
during this time. 
In one experiment, the effect of temperature on the hydrolysis of N-acetyl- 
L-tyrosine ethyl ester by eluate AE was found to parallel digestion by activated 
C'1, as tested at 25  ° and 37°C. OSCAR D.  RATNOF~' AND  IRWIN  H.  LEPOW  337 
The apparent energy of activation for the hydrolysis of N-acetyl-r.-tyrosine 
ethyl ester by activated C'I was calculated from the data in Fig. 3, using the 
Arrhenius equation (17): V =  z¢-,/~ in which V is the velocity of the reaction, 
z is a constant, e is the base of natural logarithms, T is the absolute temperature, 
R  is the gas constant, and/~ is the critical thermal increment or energy of 
activation. In biological systems, the value g has also been called "the tempera- 
ture characteristic"  (18)  and may not be  identical with the  energy of acti- 
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FIG. 3.  The relationship between temperature and the rate of hydrolysis of N-acetyl-L- 
tyrosine ethyl ester by activated C'I and by the eluate factor. The temperature is plotted as 
the reciprocal of the absolute temperature, but the legend appears in terms of the centrigrade 
scale for convenience. 
vation. In Fig. 3, the method of least mean squares was used to determine the 
slope of the curve and a value for tt of 12,000 calories per tool. was calculated 
between 25  ° and 38°C. 
(e)  Ionic  Strength.--The  kinetic  studies which have  been  described  were 
performed at an ionic strength of approximately 0.15, ignoring the contribution 
of the substrate itself to ionic strength. The influence of ionic strength on the 
amount of acid liberated during the incubation of activated C'I and N-acetyl- 
L-tyrosine ethyl ester was tested at 37°C. (Table III). Within the range tested, 
the rate of hydrolysis of the substrate was not appreciably influenced until the 
ionic strength of the mixture was increased above 0.250. At higher salt concen- 
trations, enzymatic activity was moderately inhibited. 338  AN ESTERASE DERIVED FROM  COMPLEMENT 
3. Inhibition of Activated C'I: 
The influence of various substances on the enzymatic activity of activated 
C'I  was  tested,  using N-acetyl-L-tyrosine ethyl ester  as  substrate.  Human 
serum inhibited the digestion of this substrate (Table IV). The inhibitory effect 
of serum could be demonstrated as  soon as it was mixed with activated Cq. 
Incubation  of serum and activated C'I  at 37°C. for 30 minutes prior to  the 
addition of substrate did not increase inhibition of the enzyme. The inhibitory 
property was greatly diminished by heating fresh serum at 56°C. for 30 minutes, 
and to a  lesser degree by preliminary incubation of the serum with strepto- 
kinase. The inhibitory property was non-dialyzable. It could not be identified 
with the known components of complement (Table IV). A  fraction of serum 
deficient in the second component of complement (R2)  lacked the inhibitory 
TABLE III 
The Influence of Ionic Strength on the Hydrolysis of N-ac.etyl-L-tyrosine Ethyl Ester by 
A ctivated C'I 
Ionic strength of enzyme-substrate  mixture  Microequivalents  of acid liberated  in 15 minutes 
O. 075 
0.100 
O. 125 
O. 150 
0.200 
0.250 
0.350 
0.500 
8.8 
8.5 
7.7 
8.2 
8.9 
7.9 
7.2 
6.1 
effect. However, complement-fixed serum, in which no detectable amount of the 
second component was  present, had the same inhibitory effect as  untreated 
serum.  Presumably,  then,  the  inhibitory property of serum was  related to 
something which was deficient in the R2 fraction and yet was not inactivated 
by complement fixation. The fraction of serum responsible for the inhibition of 
the esterase did not survive the fractionation of human plasma by the method 
of  Cohn,  for  fractions  prepared  in  this  manner  lacked  inhibitory activity. 
Indeed, fractions I  and III appreciably hydrolyzed N-acetyl-L-tyrosine ethyl 
ester. 
Pancreatic  trypsin  inhibitor,  soy bean  inhibitor,  egg white trypsin inhibitor, 
heparin,  and  disodium  ethylenediamine  tetraacetic  acid  did  not  appear  to 
affect the digestion of N-acetyl-L-tyroslne ethyl ester by activated C'I in  the 
concentrations  tested.  The  preparation  of  diisopropyl fluorophosphate  used 
inhibited the esterase only in a concentration of 1.25 X  10  -8~r or higher; at this 
concentration, visible precipitation was observed. 
Several reducing and  oxidizing agents  were tested for their effect on the OSCAR  D.  RATNOFF  AND  IRWIN  H.  LEPOW  339 
activity of the esterase.  Although ascorbate did not appear  to be  inhibitory, 
cysteine, reduced glutatkione,  and tkioglycoUic avid all diminished the activity 
of the enzyme (Table IV C). The action of these substances  appeared to be on 
the enzyme rather than on the substrate, since little or no effect was observed 
unless the inhibitor and enzyme were incubated together at 37°C. for a period 
of 30 minutes before the addition of substrate. On the other hand, peroxide and 
TABLE  IV 
The Inhibitory Effect of Certain Agents on the Digestion of N-acetyl-L-tyrosine Ethyl 
Ester by Activated C'I 
Microequlvalents 
Agents  of acid liberated 
in 15 minutes 
A.  1.  0.15 N sodium chloride ........................................ 
2.  Human serum ............................................... 
3.  56°C. heated serum ........................................... 
4.  *  R1  ........................................................ 
5.  P,2* ........................................................ 
6.  R3* ........................................................ 
7.  R4* ....................................................... 
B.  1.  0.1S N sodium chloride ....................................... 
2.  Human serum .............................................. 
3.  Human serum (diluted to 50 per cent) ......................... 
4.  Complement-fixed serum ..................................... 
5.  Streptokinase treated serum .................................. 
C.  1.  0.15 N sodium chloride ....................................... 
2.  0.02 ~x sodium ascorbate ...................................... 
3.  0.02 xt cysteine .............................................. 
4.  0.02 ~s reduced glutathione ................................... 
5.  0.02 v  sodium thioglycollate .................................. 
6.9 
0 
8.0 
0 
6.8 
0.2 
0.6 
8.1 
0.7 
3.5 
1.0 
3.5 
7.9 
8.2 
4.0 
4.5 
1.2 
A, B, and C  represent separate experiments. 
* RI, 2, 3, and 4 represent preparations of serum deficient respectively in the first, second, 
third, and fourth components of complement. 
oxidized glutathione did not inhibit digestion  of N-acetyl-T.-tyrosine ethyl ester 
under the conditions  tested. The inhibition of activated C'1 by thioglycollic 
acid could not be reversed by subsequent incubation with oxidized glutathione. 
The  presumed  end-product  of the  digestion  of N-acetyl-L-tyrosine  ethyl 
ester, N-acelyl-L-tyrosine,  tested at a concentration of 0.02 ~,  did not inhibit 
activated C'1. 
DISCUSSION 
The  possibility  that  complement  exerts its hemolytic  effect on sensitized  red 
cells through  an  enzymatic  process  has  intrigued  investigators  for many  years. 340  AN  ESTERASE  DERIVED  I~ROM  COMPLEMENT 
This hypothesis was.advanced as early as 1910 by Liefmann (19), and his ideas 
were apparently foreshadowed by Ehrlich. Others occasionally defended these views 
(1, 20-23),  but the demonstration of the enzymatic nature of complement has been 
elusive. In 1954, we suggested on the basis of studies on the effect of plasmin that the 
first component of complement was the precursor of an enzyme (1). Investigation of 
the properties of preparations derived from the first component of complement has 
confirmed and extended this hypothesis,  for such preparations digested  certain syn- 
thetic amino  acid  esters  (4, 5).  Similarly  Levine (6) and Becker (7) reported that 
hemolysis  by guinea pig complement was inhibited by diisopropyl  fluorophosphate, 
which  is known to inhibit esterases  and other hydrolytic enzymes.  The inhibitory 
effect of diisopropyl  fluorophosphate  was  directed primarily against the first com- 
ponent of complement, which was therefore thought to be the precursor of an esterase 
(7).  Using different techniques,  Becker (8) has confirmed  our observation that the 
first component of complement is the precursor of an enzyme which will hydrolyze 
p-toluenesulfonyl-L-arginine methyl ester. 
In the present study, the properties of the estemse derived from preparations 
of the first component of complement have been examined further. Four addi- 
tional substrates have been found, all esters of amino acids  (Table I).  The 
hydrolysis of these compounds by the enzyme derived from the first component 
occurred at the ester linkage. No evidence has yet been adduced of hydrolysis 
of proteins, peptides,  or amides.  However, it is possible that in nature such 
compounds may be digested, for the esterase appears to inactivate the second 
and fourth components of complement by a mechanism which is not yet under- 
stood (4, 5). The spectrum of susceptible substrates seems to differentiate the 
estrase derived from complement from such other enzymes as trypsin, chymo- 
trypsin, serum peptidase, serum acid or alkaline phosphatase, cholinesterase, 
plasmin, and thrombin. 
Another idea old to immunology has been that antigen-antibody reactions in 
some manner release enzymatic activity (24-27), but again the evidence that 
has been offered has been controversial. In a preliminary report, it was demon- 
strated that antigen-antibody aggregates partially removed an enzyme or its 
precursor from serum  (5).  An  esterase was  eluted from such  serum-treated 
aggregates which had properties remarkably similar to those of the enzyme 
derived from preparations of the first component of complement. In the present 
report, the parallelism between the properties of the esterase obtained from 
these two sources has been extended, for both hydrolyzed the same substmtes, 
both inhibited the second and fourth components of complement, and both had 
the same apparent energy of activation. An esterase with similar properties 
could also be found in fractions I  and III of human plasma, prepared by the 
method of Cohn? 
a Fractions of plasma prepared by the method of Cohn were provided through the courtesy 
of the late Dr. E. J. Cohn, Boston, and E. R. Squibb Division, Mathieson Chemical Company. OSCAR D. RATNOF]~ AND  IRWIN H. LEPOW  341 
Experiments have  also  been  described  demonstrating that  human serum 
inhibited the esterase (Table IV). The inhibitory property was heat labile and 
did not survive fractionation of plasma by the method of Cohn. The inhibitory 
property was also partially destroyed by the addition of streptokinase, but it 
could not be identified with any of the known components of complement. The 
enzyme could also be inhibited by sulfhydryl compounds,  but this inhibition 
did not appear to result from the reversible reduction of disulfide bonds. 
The data which have been reported support the hypothesis presented earlier 
(1) that the first component of complement is converted into an active form 
during the course of antigen-antibody reactions. At that time, it was suggested 
that streptokinase inhibited complement by converting the first component 
into an agent which in turn inhibited the second and fourth components (1). 
Experiments now in progress  indicate that the addition of streptokinase to 
preparations of the first component does activate the esterase which has been 
described.  This appears  to be direct evidence in support of the foregoing hy- 
pothesis. 
Finally it must be pointed out that no physiologic role for the esterase has 
been uncovered.  It is tempting to suggest that this enzyme prepares the erythro- 
cyte or other cells sensitized by specific antibody, for the hemolytic or cytotoxic 
action of one or another of the other components of complement. Experiments 
designed to test this hypothesis are under way. 
SUMMARY 
Studies on an esterasc derived from partially purified preparations of the 
first  component of complement are described. The esterase hydrolyzed certain 
synthetic amino acid esters,  among which N-acetyl-L-tyrosine  ethyl ester  was 
most susceptible. This was hydrolyzed maximally  between  pH  7.5 and 8.2, 
and at  41°C. The esterase  could not be identified  with other  previously described 
hydrolytic  enzymes. An esterase with similar  properties could also be eluted 
from antigen-antibody aggregates which had been treated with serum. 
Human  serum contained a heat-labile inhibitor of the csterase which could 
not be identified with any of the known  components  of complement.  The 
esterase was also  inhibited by certain reducing agents. 
The experiments described  support the early hypothesis that complement 
exerts its  action enzymatically, but the physiological role  of  the esterase  derived 
from preparations  of complement is not yet clear. 
This  study  could  not  have been  completed  without  the  technical  assistance  of  Miss Joan E. 
Colopy,  Miss Sedell  Millman,  Miss Ann M. Harris,  and Mr. Lawrence R. Levy.  The myome- 
trial  suspension  was  prepared  by  Dr.  Jcrold  M. Rosenblum. Certain  of  the  synthetic  substrates 
were prepared  by Mr. A. A. Arters  in the Department of Chemistry,  Western Reserve  Uni- 
versity.  Dr. Florence  Roth performed the assays  for  gelatinase  activity.  Dr. Sol Sherry,  St. 
Louis,  provided  L-lysine  ethyl  ester,  as well  as invaluable  technical  suggestions  at the outset 
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